AIRLINK 141.00 Increased By ▲ 9.73 (7.41%)
BOP 10.10 Increased By ▲ 0.33 (3.38%)
CNERGY 6.98 Increased By ▲ 0.35 (5.28%)
CPHL 81.49 Increased By ▲ 5.40 (7.1%)
FCCL 43.09 Increased By ▲ 2.54 (6.26%)
FFL 14.95 Increased By ▲ 1.12 (8.1%)
FLYNG 52.75 Increased By ▲ 3.69 (7.52%)
HUBC 137.48 Increased By ▲ 5.49 (4.16%)
HUMNL 11.29 Increased By ▲ 0.44 (4.06%)
KEL 5.16 Increased By ▲ 0.27 (5.52%)
KOSM 5.41 Increased By ▲ 0.41 (8.2%)
MLCF 82.45 Increased By ▲ 6.12 (8.02%)
OGDC 214.10 Increased By ▲ 10.24 (5.02%)
PACE 5.61 Increased By ▲ 0.29 (5.45%)
PAEL 37.75 Increased By ▲ 2.76 (7.89%)
PIAHCLA 21.22 Increased By ▲ 1.26 (6.31%)
PIBTL 8.10 Increased By ▲ 0.47 (6.16%)
POWER 13.50 Increased By ▲ 0.82 (6.47%)
PPL 163.26 Increased By ▲ 9.93 (6.48%)
PRL 31.67 Increased By ▲ 1.68 (5.6%)
PTC 23.25 Increased By ▲ 1.69 (7.84%)
SEARL 83.60 Increased By ▲ 5.67 (7.28%)
SSGC 41.15 Increased By ▲ 2.35 (6.06%)
SYM 14.10 Increased By ▲ 1.15 (8.88%)
TELE 7.35 Increased By ▲ 0.38 (5.45%)
TPLP 9.22 Increased By ▲ 0.42 (4.77%)
TRG 53.76 Increased By ▲ 2.67 (5.23%)
WAVESAPP 8.96 Increased By ▲ 0.55 (6.54%)
WTL 1.43 Increased By ▲ 0.08 (5.93%)
YOUW 4.66 Increased By ▲ 0.44 (10.43%)
BR100 12,258 Increased By 484.3 (4.11%)
BR30 37,041 Increased By 2066.7 (5.91%)
KSE100 120,684 Increased By 4516.5 (3.89%)
KSE30 36,752 Increased By 1344.5 (3.8%)

KARACHI: The Chemists and Druggists have called for finding alternative sources for pharmaceutical raw materials following the suspension of trade with India.

Last year, Pakistan’s pharmaceutical industry recorded $305 million in trade with India.

Druggists said vaccines, biological products, and cancer medicines can now be imported from countries like China, Indonesia, Malaysia, and Europe. It noted that while Indian raw materials were cheaper, they were often of lower quality compared to alternatives available globally.

Since tensions with India in 2019, efforts have been underway to reduce reliance on Indian pharmaceutical imports.

Chairman Pakistan Chemists and Druggists Association (PCDA) urged the Drug Regulatory Authority of Pakistan (DRAP) to accelerate the registration of high-quality medicines from new sources to meet local demand.

Samad emphasized that Pakistan can fully leverage international markets and does not solely depend on Indian supplies.

Copyright Business Recorder, 2025

Comments

Comments are closed.